Vimarsana
Biggest News Aggregation in the World

Merck Sharp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Merck Sharp Today - Breaking & Trending Today

New test detects more cases of cervical cancer - Vimarsana News

New test detects more cases of cervical cancer

Researchers have developed a simpler and more effective screening method for cervical cancer than the method used today. A comprehensive study shows that the test detects significantly more cancers and precancerous stages.

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules - Vimarsana News

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

Amanda Leach and colleagues compare two pneumococcal conjugate vaccines to examine the impact on hearing loss

Source: plos.org
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting - Vimarsana News

Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in...

TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders - Vimarsana News

TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders

Regulatory News: TME Pharma N.V. , a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment , announced today that the annual...

Alnylam Pharmaceuticals (NASDAQ:ALNY) versus Vaccinex (NASDAQ:VCNX) Critical Contrast - Vimarsana News

Alnylam Pharmaceuticals (NASDAQ:ALNY) versus Vaccinex (NASDAQ:VCNX) Critical Contrast

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and Vaccinex (NASDAQ:VCNX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends. Analyst Recommendations This is a summary of recent recommendations […]